Company / Book Value per Share
SAB Biotherapeutics, Inc. Book Value per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.796
FY2025
5-year range
$0.296 / $6.211
FY2021-FY2025
Trend
-55.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $6.162 to $2.796 over the past 2 years.
Based on SEC 10-K filings.
$2.796 in FY2025 with a 3-year CAGR of +23.0%.
Declined from $6.162 to $2.796 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +23.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +23.0%, indicating consistent growth.
- In FY2025, book value per share decreased 55.0% year-over-year.
- Peak book value per share was recorded in FY2024.
- Lowest book value per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.31 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.796 | -55.0% |
| FY2024 | $6.211 | +0.8% |
| FY2023 | $6.162 | +310.3% |
| FY2022 | $1.502 | +407.0% |
| FY2021 | $0.296 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026